Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025)
Dianthus Therapeutics' quarterly Current Leases came in at $367000.0 in Q4 2025, up 14.69% year-on-year from $320000.0 in Q4 2024, and up 69.12% quarter-over-quarter from $217000.0 in Q3 2025.
Dianthus Therapeutics has reported Current Leases for 4 years, with the latest figure at $367000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 14.69% year-over-year to $367000.0; the trailing twelve-month figure through Dec 2025 stood at $367000.0 (up 14.69% YoY), and the FY2025 full-year result was $367000.0, up 14.69% from the prior year.
- Current Leases for Q4 2025 stood at $367000.0, up from $217000.0 in the prior quarter.
- The five-year high for Current Leases was $3.6 million in Q3 2022, with the low at $211000.0 in Q2 2025.
- Average Current Leases over 4 years is $992785.7, with a median of $372000.0 recorded in 2024.
- Peak annual rise in Current Leases reached 19.14% in 2023, while the deepest fall reached 88.59% in 2023.
- Tracing DNTH's Current Leases over 4 years: stood at $350000.0 in 2022, then advanced by 19.14% to $417000.0 in 2023, then dropped by 23.26% to $320000.0 in 2024, then rose by 14.69% to $367000.0 in 2025.
- The last three Current Leases figures came in at $367000.0 (Q4 2025), $217000.0 (Q3 2025), and $211000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | 367,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 211,000.00 |
| Mar 31, 2025 | 226,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 417,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.25 Mn |